Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Bioventus Q4 Sales $130.40M Beat $130.29M Estimate

Bioventus (NASDAQ:BVS) reported quarterly sales of $130.40 million which beat the analyst consensus estimate of $130.29 million by 0.08 percent. This is a 32.26 percent increase over sales of $98.59 million the same

byBill Haddad

March 10, 2022

1 minute read

Bioventus (NASDAQ:BVS) reported quarterly sales of $130.40 million which beat the analyst consensus estimate of $130.29 million by 0.08 percent. This is a 32.26 percent increase over sales of $98.59 million the same period last year.